XML 85 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
OPERATING ACTIVITIES      
Net income (loss) $ 967 $ 1,917 $ 2,625
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Provision for credit losses 489 502 (418)
Depreciation and amortization expense, net 134 137 32
Accretion of acquired loans 20 27 24
Increase in cash surrender value of corporate-owned life insurance (110) (113) (113)
Stock-based compensation expense 121 120 104
Deferred income taxes (benefit) (108) (27) 146
Proceeds from sales of loans held for sale 8,859 12,496 16,114
Originations of loans held for sale, net of repayments (8,434) (10,684) (16,497)
Net losses (gains) from sale of loans held for sale (135) (151) (282)
Net losses (gains) on leased equipment (9) 7 (12)
Net securities and other investments losses (gains) 11 (9) (7)
Net losses (gains) on sales of fixed assets 18 (7) 18
Net decrease (increase) in trading account assets (313) (128) 34
Net transfer of loans held for sale 0 0 0
Other operating activities, net 1,393 382 (615)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 2,903 4,469 1,153
INVESTING ACTIVITIES      
Purchases of intangible assets via acquisitions 0 (12) 0
Cash received (used) in acquisitions, net of cash acquired 0 (58) (29)
Net decrease (increase) in short-term investments, excluding acquisitions (8,385) 8,578 5,184
Purchases of securities available for sale (2,160) (4,473) (28,190)
Proceeds from sales of securities available for sale 1,752 0 1,375
Proceeds from prepayments and maturities of securities available for sale 3,225 4,545 7,623
Proceeds from prepayments and maturities of held-to-maturity securities 1,343 2,291 2,889
Purchases of held-to-maturity securities (1,194) (3,670) (3)
Purchases of other investments (599) (667) (55)
Proceeds from sales of other investments 646 17 41
Proceeds from prepayments and maturities of other investments 11 15 26
Net decrease (increase) in loans, excluding acquisitions, sales, and transfers 6,668 (17,649) (4,276)
Proceeds from sales of portfolio loans 151 157 337
Proceeds from corporate-owned life insurance 96 72 72
Purchases of premises, equipment, and software (142) (96) (66)
Proceeds from sales of premises and equipment 5 16 4
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 1,417 (10,934) (15,068)
FINANCING ACTIVITIES      
Net increase (decrease) in deposits, excluding acquisitions 2,992 (9,977) 17,290
Net increase (decrease) in short-term borrowings (6,372) 8,702 (218)
Net proceeds from issuance of long-term debt 5,240 16,596 1,203
Payments on long-term debt (5,052) (8,580) (2,566)
Repurchases of long-term debt (92) 0 0
Issuance of preferred shares 0 590 0
Open market common share repurchases (38) 0 (559)
Employee equity compensation program Common Share repurchases (34) (44) (32)
Common share purchases under ASR program 0 0 (585)
Net proceeds from reissuance of Common Shares 1 6 27
Cash dividends paid (911) (854) (823)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (4,266) 6,439 13,737
NET INCREASE (DECREASE) IN CASH AND DUE FROM BANKS 54 (26) (178)
CASH AND DUE FROM BANKS AT BEGINNING OF YEAR 887 913 1,091
CASH AND DUE FROM BANKS AT END OF YEAR 941 887 913
Additional disclosures relative to cash flows:      
Interest paid 3,109 601 363
Income taxes paid 156 292 277
Noncash items:      
Reduction of secured borrowing and related collateral 6 9 9
Loans transferred to portfolio from held for sale 208 105 87
Loans transferred to held for sale from portfolio 19 0 3,403
Loans transferred to other real estate owned 7 6 4
CMBS risk retentions 0 12 28
ABS risk retentions 7 8 11
Securities received as consideration $ 0 $ 0 $ 2,825